Global Yervoy Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Yervoy Market Insights, Forecast to 2034
Yervoy is a cancer medicine used in adults and adolescents from 12 years of age with advanced melanoma (a type of skin cancer) and in adults with advanced renal cell carcinoma (a kidney cancer).
Global Yervoy market is expected to reach to US$ 2057 million in 2024, with a positive growth of %, compared with US$ 2131 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Yervoy industry is evaluated to reach US$ 1811.1 million in 2029. The CAGR will be -2.1% during 2024 to 2029.
Yervoy is a medication used for the treatment of advanced melanoma and certain types of cancers. The market for Yervoy is driven by factors such as the increasing incidence of melanoma and the growing demand for effective immunotherapies. Yervoy has demonstrated promising results in prolonging survival and improving outcomes for patients with advanced melanoma. The market is also influenced by factors such as the expanding oncology pipeline, advancements in cancer research, and the increasing adoption of targeted therapies. However, the market faces challenges such as high treatment costs and competition from other immunotherapies. Despite these challenges, Yervoy continues to hold a significant market share due to its efficacy and clinical benefits. As research and development in the field of immunotherapy continue, the Yervoy market is expected to witness steady growth in the coming years.
Report Covers
This report presents an overview of global Yervoy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Yervoy market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Bristol-Myers Squibb
Segment by Type
40ml
10ml
Hospital
Drugs Store
Other
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Yervoy plant distribution, commercial date of Yervoy, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Yervoy introduction, etc. Yervoy Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Yervoy
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Yervoy market is expected to reach to US$ 2057 million in 2024, with a positive growth of %, compared with US$ 2131 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Yervoy industry is evaluated to reach US$ 1811.1 million in 2029. The CAGR will be -2.1% during 2024 to 2029.
Yervoy is a medication used for the treatment of advanced melanoma and certain types of cancers. The market for Yervoy is driven by factors such as the increasing incidence of melanoma and the growing demand for effective immunotherapies. Yervoy has demonstrated promising results in prolonging survival and improving outcomes for patients with advanced melanoma. The market is also influenced by factors such as the expanding oncology pipeline, advancements in cancer research, and the increasing adoption of targeted therapies. However, the market faces challenges such as high treatment costs and competition from other immunotherapies. Despite these challenges, Yervoy continues to hold a significant market share due to its efficacy and clinical benefits. As research and development in the field of immunotherapy continue, the Yervoy market is expected to witness steady growth in the coming years.
Report Covers
This report presents an overview of global Yervoy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Yervoy market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bristol-Myers Squibb
Segment by Type
40ml
10ml
Segment by Application
Hospital
Drugs Store
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Yervoy plant distribution, commercial date of Yervoy, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Yervoy introduction, etc. Yervoy Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Yervoy
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices